Search Results 3391-3400 of 25032 for oral

  1. Study finds few COVID-19 patients get rebound symptoms after Paxlovid treatment - Mayo Clinic News Network

    ROCHESTER, Minn. — Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir ...

  2. Ryan J. Solinsky, M.D. - Doctors and Medical Staff - Mayo Clinic

    2017. Golden Apple Teaching Award NomineeRutgers University, New Jersey Medical School. 2017. Best Oral Presentation AwardInternational Autonomic Symposium, ...

  3. Lewis R. Roberts, M.B., Ch.B., Ph.D.

    MemberOral Qualifying Exam for Lang Wu, Mayo Clinic Center for Clinical and Translational Sciences. 2013. MemberMayo Clinic Rochester; Thesis Advisory ...

  4. Gynecological care for trans men - Mayo Clinic

    Sexually transmitted infection tests. You can get a sexually transmitted infection from oral, anal or vaginal sex. These infections include chlamydia, gonorrhea ...

  5. Publications - Norio Fukami, M.D. - Mayo Clinic

    Per-oral video cholangiopancreatoscopy with narrow-band imaging for the evaluation of indeterminate pancreaticobiliary disease. Gastrointest Endosc. 2017 ...

  6. Budesonide, glycopyrrolate, and formoterol (inhalation route) - Mayo Clinic

    May cause these conditions to reappear in patients who have been previously treated with oral corticosteroids. Asthma attack, acute or; Bronchospasm ...

  7. Matt R. Starr, M.D. - Doctors and Medical Staff - Mayo Clinic

    Writing CommitteeWritten Qualifying Examination (WQE) and Oral Examination Committees, American Board of Ophthalmology. 2024 - present. ExaminerWritten ...

  8. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis - Mayo Clinic

    Subjects who have initiated or had a dose change of any of the following within 2 weeks of screening: oral, topical, or intravenous (IV) vasodilators (e.g. ...

  9. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Mayo Clinic

    Oral glutamine;; Proton pump inhibitors;; Diuretics;; Systemic antibiotics or antibiotics affecting the gastrointestinal tract;; Oral rehydration fluids.

  10. A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of GZ/SAR402671 in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation - Mayo Clinic

    - To assess the pharmacodynamic response to daily oral dosing of GZ/SAR402671 in plasma and CSF as measured by glucosylceramide (GL-1) when administered in ...